Development of Inflammatory Models Using Differentiated Human Bronchial Epithelial (HBE) Cells from Cystic Fibrosis Patients for the Pre-Clinical Evaluation of Novel Therapeutic Compounds
This study establishes and validates a robust ex vivo model of cystic fibrosis airway inflammation using differentiated primary human bronchial epithelial cells from patients, demonstrating its efficacy in reproducing key inflammatory responses to various stimuli and highlighting its potential as a valuable tool for preclinical evaluation of novel anti-inflammatory therapies.